133 related articles for article (PubMed ID: 1695827)
1. Androgen metabolism in different target tissues.
Martini L; Celotti F; Lechuga MJ; Melcangi RC; Motta M; Negri-Cesi P; Poletti A; Zoppi S
Ann N Y Acad Sci; 1990; 595():184-98. PubMed ID: 1695827
[No Abstract] [Full Text] [Related]
2. Testosterone 5 alpha-reductase and the accumulation of dihydrotestosterone in benign prostatic hyperplasia.
Cowan RA; Cook B; Cowan SK; Grant JK; Sirett DA; Wallace AM
J Steroid Biochem; 1979 Jul; 11(1B):609-13. PubMed ID: 90753
[No Abstract] [Full Text] [Related]
3. Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate.
Habib FK; Tesdale AL; Chisholm GD; Busuttil A
J Endocrinol; 1981 Oct; 91(1):23-32. PubMed ID: 6170712
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
Krieg M; Bartsch W; Janssen W; Voigt KD
J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
[No Abstract] [Full Text] [Related]
5. Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle.
Isaacs JT
J Steroid Biochem; 1983 Jun; 18(6):749-57. PubMed ID: 6191128
[TBL] [Abstract][Full Text] [Related]
6. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
Isaacs JT; Brendler CB; Walsh PC
J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
[TBL] [Abstract][Full Text] [Related]
7. Androgen binding and metabolism in the human prostate.
Attramadal A; Tveter KJ; Weddington SC; Djöseland O; Naess O; Hansson V; Torgersen O
Vitam Horm; 1975; 33():247-64. PubMed ID: 59460
[No Abstract] [Full Text] [Related]
8. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
Baranowska B; Zgliczyński S
Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
[TBL] [Abstract][Full Text] [Related]
9. Androgen receptors in male sex tissues of rats and humans.
Attramadal A; Weddington SC; Naess O; Djoseland O; Hansson V
Prog Clin Biol Res; 1976; 6():189-203. PubMed ID: 66689
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the nuclear 5 alpha-reduction of testosterone and androstenedione in human prostatic carcinoma and benign prostatic hyperplasia.
Hudson RW; Wherrett D
J Steroid Biochem; 1990 Feb; 35(2):231-6. PubMed ID: 1689784
[TBL] [Abstract][Full Text] [Related]
11. Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
Horton R
J Am Geriatr Soc; 1984 May; 32(5):380-5. PubMed ID: 6201524
[No Abstract] [Full Text] [Related]
12. NAD(P)H-quinone oxidoreductase 1 silencing aggravates hormone-induced prostatic hyperplasia in mice.
Kim HT; Kim YJ; Park SR; Ryu SY; Jung JY
Andrologia; 2018 Apr; 50(3):. PubMed ID: 29110315
[TBL] [Abstract][Full Text] [Related]
13. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.
Siiteri PK; Wilson JD
J Clin Invest; 1970 Sep; 49(9):1737-45. PubMed ID: 4194768
[TBL] [Abstract][Full Text] [Related]
14. Natural anti-androgen progesterone.
Wright F; Kirchhoffer MO; Giacomini M
Ann Endocrinol (Paris); 1979; 40(3 Suppl):282-93. PubMed ID: 496377
[No Abstract] [Full Text] [Related]
15. Effect of zinc on androgen metabolism in the human hyperplastic prostate.
Wallace AM; Grant JK
Biochem Soc Trans; 1975; 3(4):540-2. PubMed ID: 1183718
[No Abstract] [Full Text] [Related]
16. Human prostatic cells in culture: different testosterone metabolic profile in epithelial cells and fibroblasts from normal or hyperplastic prostates.
Berthaut I; Portois MC; Cussenot O; Mowszowicz I
J Steroid Biochem Mol Biol; 1996 May; 58(2):235-42. PubMed ID: 8809206
[TBL] [Abstract][Full Text] [Related]
17. Androgen assimilation by normal and hyperplastic dog prostate glands.
Mawhinney MG; Schwartz FL; Thomas JA; Lloyd JW
Invest Urol; 1974 Jul; 12(1):17-22. PubMed ID: 4135034
[No Abstract] [Full Text] [Related]
18. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
[No Abstract] [Full Text] [Related]
19. Interferences of zearalenone, zearalanol or estradiol-17 beta with the steroid-metabolizing enzymes of the human prostate gland.
Thouvenot D; Morfin RF
J Steroid Biochem; 1980 Nov; 13(11):1337-45. PubMed ID: 6161277
[No Abstract] [Full Text] [Related]
20. (De)phosphorylation agents influence 5 alpha-reduction of testosterone in human prostate.
Le Goff JM; Martin PM; Raynaud JP
Endocrinology; 1988 Sep; 123(3):1693-5. PubMed ID: 2456919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
